Bruker

Bruker is a developer and manufacturer of high-performance scientific instruments and solutions for molecular and materials research as well as industrial and applied analysis. The company supplies instruments and diagnostic tests to customers in the life sciences, pharmaceutical, and biotechnology sectors and serves academia and industry with platforms for chemistry, biology, materials characterization, and energy-related applications. It broadens its offering through specialized cell biology tools for live single-cell analysis, enabling high-throughput phenotypic studies in oncology, immunology, and cell therapy. Asia Pacific is a key geographic market for Bruker.

Rohan Thakur

President

57 past transactions

RECIPE

Acquisition in 2025
RECIPE is a clinical kit manufacturer with a focus on CE-IVD solutions for HPLC and LC-MS/MS kits. Full kits for LC-MS/MS, HPLC, and photometry are among their offerings, along with calibrators, controls, optimization mixes, internal standards, and instruments. MS/MS parameter optimization and the ensuing analytical system verification are the goals of optimization mixtures.

Terrain Bio

Seed Round in 2025
Terrain BioSciences is in the field of RNA-based therapeutics and vaccine development. Leveraging advanced AI and proprietary manufacturing platforms, Terrain BioSciences addresses the challenges of designing, selecting, manufacturing, and delivering optimal RNA sequences. Terrain BioSciences collaborates with over a dozen biotech firms to enhance the expression, durability, and manufacturability of RNA sequences, significantly accelerating their path to clinical application. With a focus on personalized cancer vaccines and other RNA-based modalities, Terrain BioSciences is at the forefront of the next generation of programmable medicines.

PrognomIQ

Series D in 2024
PrognomiQ is a technology company specializing in transforming the early detection and treatment of complex diseases like cancer. It generates comprehensive proteomic, genomic, and metabolomic data to provide insights into these conditions, aiming to enhance patient outcomes. The company's innovative approach involves developing advanced test products that improve understanding and management of health issues by integrating diverse health data types.

Dynamic Biosensors

Acquisition in 2024
Dynamic Biosensors GmbH is a Munich-based company specializing in biomolecular interaction analysis solutions. The company has developed the switchSENSE platform, which includes the switchSENSE Analyzer and switchSENSE Biochip. These products facilitate label-free interaction analysis by employing switchable DNA interfaces to measure molecular interactions with high sensitivity and precision. The switchSENSE technology is particularly beneficial for applications such as protein-protein, DNA-protein, and DNA-DNA analyses. By providing advanced measurement capabilities, Dynamic Biosensors aims to enhance the efficiency and quality of molecular measurements in the biotechnology sector, ultimately aiding in the identification of pharmaceutical substances.

NovAliX

Corporate Round in 2024
NovAliX is a research organization specializing in drug discovery and pharmaceutical development. It provides a range of integrated services designed to address the outsourcing needs of the pharmaceutical industry, from initial discovery through to manufacturing. Utilizing proprietary technologies such as surface plasmon resonance (SPR), X-ray protein crystallography, and advanced NMR techniques, NovAliX offers comprehensive support for small molecule drug discovery and biologics characterization. The company's collaborative approach enables clients to access a unique combination of screening, medicinal chemistry, and structural biology, facilitating the development of effective drugs. Additionally, NovAliX conducts thorough analyses of active pharmaceutical ingredients (APIs) and polymorphism studies, supporting pharmaceutical development and manufacturing teams in their efforts to bring new therapies to market.

NanoString Technologies

Acquisition in 2024
NanoString Technologies, Inc. is a life science company that specializes in providing innovative tools for translational research and molecular diagnostics globally. Founded in 2003 and headquartered in Seattle, Washington, the company developed a unique digital molecular barcoding technology for various applications in basic research and clinical diagnostics. Its flagship product, the nCounter Analysis System, consists of automated systems for sample preparation and data collection, allowing for the simultaneous profiling of numerous genes and proteins from single tissue samples. Additionally, NanoString offers the GeoMx Digital Spatial Profiler, which enhances spatial genomics research. The company also provides a range of services, including custom assay design, data analysis software, and molecular diagnostic test kits, such as Prosigna for breast cancer prognosis. Collaborations with major pharmaceutical companies and research institutions further bolster its position in advancing genomic and proteomic research.

Spectral Instruments Imaging

Acquisition in 2024
Spectral Instruments Imaging is a manufacturer of advanced imaging systems, specializing in in-vivo optical imaging for monitoring disease progression in small animals. The company offers a range of imaging modalities, including bioluminescent, fluorescent, x-ray, and optical imaging technologies. Additionally, it develops cooled high-sensitivity cameras that enable precise calibration for quantifiable imaging results. With a focus on ease of use, Spectral Instruments Imaging provides comprehensive software development and data services to support its imaging systems, catering to clients in research and clinical settings.

Chemspeed Technologies

Acquisition in 2024
Chemspeed Technologies AG is a provider of automation solutions tailored for research and development laboratories, founded in 1997 and headquartered in Füllinsdorf, Switzerland, with additional offices in North Brunswick, New Jersey, and York, United Kingdom. The company specializes in high-throughput and high-output workflow solutions, offering a range of products including the flex platform and swing/swing XL systems. Chemspeed's offerings encompass workflow packages designed for drug discovery, catalyst and formulation research, and automated chemistry solutions. Key products include the AutoSuite Workflow Management Software, which facilitates instrument control, data acquisition, and integration, along with tools for robotic applications, reactors, and vials. The company also provides application-oriented training, support services, and product integration, distributing its solutions through a network of distributors. Chemspeed serves various industries, including pharmaceuticals, material science, energy, and cosmetics, contributing to enhanced R&D productivity and efficiency.

Tornado Spectral Systems

Acquisition in 2024
Tornado Spectral Systems, founded in 2010 and based in Toronto, Canada, specializes in the design, manufacture, and distribution of optical spectrometers, particularly for Raman spectroscopy and spectral-domain optical coherence tomography (OCT). The company’s product offerings include the HyperFlux spectrometers, which provide advanced capabilities for sample identification, detection, diagnosis, and imaging. Tornado's technology features a patented High Throughput Virtual Slit (HTVS) that significantly enhances sensitivity, enabling accurate chemical analysis even in challenging conditions. Their solutions cater to diverse industries, including security, defense, biomedical, and environmental sectors, and are suitable for both laboratory use and OEM integration. Tornado's innovations facilitate real-time, non-destructive measurements, promoting broader adoption of Raman methods across various applications, such as pharmaceuticals and materials characterization. The company was previously known as Tornado Medical Systems, Inc. before rebranding in 2012.

Nion

Acquisition in 2024
Nion is a technology company specializing in the development and manufacture of electron-optical instruments, with a focus on advanced scanning transmission electron microscopes. Their products, including the u-hermes, ultrastem 200, ultrastem 500, and ultrastem 100, are designed to enhance productivity and enable new types of experiments. Nion works closely with customers to create customized devices that address specific real-world challenges, combining clean, bakeable vacuum technology, modern electron optics for high resolution, and flexible designs for post-installation modifications.

Elitech Group

Acquisition in 2023
ELITech Group SAS is a manufacturer and distributor of in vitro diagnostic equipment and reagents, focusing on clinical chemistry, microbiology, immunology, and molecular biology. Established in 1997 and headquartered in Puteaux, France, the company provides a comprehensive range of products, including clinical chemistry systems, open chemistry reagents, cytology and hematology products, immunology assays, and molecular diagnostics tools such as PCR instruments. ELITech Group addresses various medical conditions, including infectious diseases, cancer, cardiovascular diseases, and more, serving laboratories through both direct sales and an extensive distribution network that spans over 100 countries. By integrating specialized companies within the in vitro diagnostics sector, ELITech Group enhances clinical diagnostics and supports laboratories operating closer to patients.

Tome Biosciences

Series A in 2023
Tome Biosciences is a biotechnology company specializing in programmable gene insertion technology. Utilizing CRISPR, the company develops methods to insert genetic sequences of any size at various locations within any genome. This innovative approach aims to enhance the ability to detect and eliminate deoxyribonucleic acid from similar bacteriophages during infections. By advancing cell and genome engineering, Tome Biosciences seeks to provide effective therapeutic solutions for patients, paving the way for significant advancements in genetic medicine.

MIRO Analytical

Acquisition in 2023
MIRO Analytical Technologies GmbH specializes in the manufacture of advanced laser-based gas analyzers aimed at addressing global warming and air pollution. Founded in 2018 in Dübendorf, Switzerland, as a spinoff from Empa, the company leverages cutting-edge mid-infrared gas sensing technology utilizing quantum cascade lasers (QCLs). Their innovative instruments employ direct laser absorption spectroscopy to enable precise and simultaneous detection of multiple pollutants, including carbon dioxide, methane, and nitrous oxide, while minimizing the footprint and operational costs associated with gas measurements. MIRO Analytical serves a diverse clientele, including scientists, regulatory authorities, and various industries such as chemical, pharmaceutical, oil and gas, and automotive, all of which depend on accurate gas analysis for process control, emissions monitoring, and workplace safety.

PhenomeX

Acquisition in 2023
PhenomeX is a functional cell biology company that specializes in providing advanced research tools for live cell biology. The company aims to enhance researchers' understanding of cellular functions and behaviors, enabling them to unlock the full potential of each cell. By delivering deep insights into cellular function, PhenomeX supports the advancement of functional cell biology, which has the potential to improve human health significantly. Through its innovative approach, the company offers new perspectives on phenomes, facilitating more thorough research in the field of cell biology.

Zontal

Acquisition in 2023
ZONTAL is a prominent provider of digital transformation services tailored for the life sciences sector, specializing in analytical laboratory and integrated biopharma technical data solutions. The company delivers an enterprise-class, GxP-compliant data platform that enhances communication between IT systems and laboratory devices, effectively managing digital assets on a large scale. ZONTAL's innovative solutions not only reduce IT overhead but also facilitate the integration of AI and machine learning applications, optimize time-to-market, and ensure increased compliance for complex enterprises. With offices in the United States, Europe, and Asia, ZONTAL collaborates with integration and service partners to offer comprehensive global support to its clients, no matter their location or time zone.

Mercy BioAnalytics

Series A in 2023
Mercy BioAnalytics is a biotechnology company based in Natick, Massachusetts, founded in 2018 by Paul Blavin and Joseph Sedlak. The company focuses on improving cancer outcomes through early detection using a novel liquid biopsy assay platform. This platform analyzes tumor-derived extracellular vesicles, which are plentiful in blood and contain critical information about their parent cells. By leveraging these extracellular vesicles, Mercy BioAnalytics aims to enable the detection of various types of cancer at the earliest stages, thus improving the chances of successful treatment and patient survival.

Biognosys

Acquisition in 2023
Biognosys is a company at the forefront of proteomics, focusing on the precise quantification of large proteomes in biological samples. Founded as a spin-off from a leading proteomics laboratory at ETH Zurich, it aims to facilitate routine proteome analysis in research and clinical laboratories worldwide. Biognosys employs advanced high-resolution mass spectrometry techniques combined with innovative parallel signal processing to deliver detailed and high-quality protein expression data. This technology is essential for biomarker discovery and drug-target validation, significantly enhancing researchers' capabilities in personalized healthcare and life sciences. By providing valuable insights into protein analysis, Biognosys positions itself as a key player in transforming life science research.

Kiyatec

Series C in 2022
Kiyatec, LLC is a biotechnology company specializing in the development of advanced 3D cell-based assays aimed at enhancing preclinical drug discovery and clinical therapy applications. Founded in 2005 and based in Greenville, South Carolina, Kiyatec employs its proprietary 3DKUBE technology platform to create functional 3D models using patients' own living tumor cells. This innovative approach allows for the evaluation of various cancer therapies, providing insights into drug toxicity and efficacy before clinical trials. The company offers a range of services, including drug response profiling, predictions of patient responses to therapies, and cell-based assays for oncologists. Additionally, Kiyatec collaborates with biopharma clients on standard and custom assays and conducts research funded by the National Cancer Institute to develop 3D cell culture models for several types of cancer, such as breast cancer, glioblastoma, and lung cancer. By modeling complex human biology and simulating in vivo conditions, Kiyatec aims to improve treatment selection for cancer patients and support the development of medical devices and therapeutic drugs.

Haystack Oncology

Series A in 2022
Haystack Oncology is an oncology company that specializes in advanced liquid biopsy diagnostic technology aimed at improving cancer treatment strategies and patient outcomes. The company utilizes state-of-the-art circulating tumor DNA detection methods to enhance the diagnosis of minimal residual disease, allowing for more informed therapy decision-making. By analyzing tumor-specific markers in blood samples, Haystack Oncology's technology provides high sensitivity for early detection of recurrent disease, thereby enabling healthcare teams to effectively manage cancer treatment. The company's innovative approach seeks to transform how cancer is monitored and treated, ultimately benefiting patients through improved diagnostic accuracy and treatment effectiveness.

Navignostics

Seed Round in 2022
Navignostics is a biotechnology company focused on improving cancer treatment through advanced diagnostic techniques. By employing spatial single-cell proteomics, Navignostics characterizes tumors to identify the most effective treatment strategies for individual cancer patients. The company aims to reduce patient suffering by personalizing cancer therapies and ensuring that the right drug is available for each unique case. In addition to enhancing patient outcomes, Navignostics accelerates cancer drug development by offering valuable insights into drug mechanisms and tumor characteristics, which are essential for the creation of companion diagnostics. Their robust technology and data analytics capabilities position the company as a key player in precision cancer diagnostics, providing support to both patients and pharmaceutical partners in the fight against cancer.

Inscopix

Acquisition in 2022
Inscopix, Inc. is a biotechnology company based in Menlo Park, California, established in 2010. It specializes in developing advanced miniature fluorescence microscopes that enable real-time brain imaging and mapping. Inscopix's innovative technologies, including the nVista, nVoke, and nVue systems, provide neuroscientists with tools to visualize large-scale neural activity in freely behaving subjects. This capability allows researchers to connect neural circuit dynamics with corresponding behaviors, facilitating breakthroughs in understanding brain health and diseases. The company's offerings support various applications such as calcium imaging, optogenetics, blood flow imaging, and neurotransmitter imaging. By providing these cutting-edge tools, Inscopix empowers medical researchers to explore new approaches in neuroscience and contribute to significant scientific discoveries.

Tofwerk

Corporate Round in 2022
Tofwerk, established in Switzerland in 2002, specializes in designing and manufacturing advanced analytical instrumentation utilizing time-of-flight mass spectrometry (TOFMS) technology. The company offers a range of research mass spectrometers that enhance speed and sensitivity for various laboratory and field applications. Tofwerk is committed to environmental protection by providing solutions for chemical analysis, including custom spectrometer systems that employ focused ion beam technology for real-time analysis of volatile organic and inorganic compounds. Their instruments are instrumental in detecting particles across nanotechnology, biochemistry, and semiconductor manufacturing processes. The team also collaborates with research laboratories and original equipment manufacturers to create tailored instrument solutions based on a modular design platform.

Optimal Industrial Automation

Acquisition in 2022
Optimal Industrial Automation provides software services and systems integration for manufacturing automation. It offers design and build capabilities and serves clients across pharmaceutical, chemical, food and beverage, aerospace, defense, and green energy sectors. Services include batch and continuous process engineering, electrical services, robotics, product serialization, and training, helping clients build, integrate, and optimize automated production systems.

PrognomIQ

Venture Round in 2022
PrognomiQ is a technology company specializing in transforming the early detection and treatment of complex diseases like cancer. It generates comprehensive proteomic, genomic, and metabolomic data to provide insights into these conditions, aiming to enhance patient outcomes. The company's innovative approach involves developing advanced test products that improve understanding and management of health issues by integrating diverse health data types.

Preomics

Series B in 2022
PreOmics GmbH is a biotechnology company based in Planegg, Germany, specializing in mass spectrometry (MS)-based proteomics. Founded in 2016 as a spin-off from the Max-Planck Institute of Biochemistry, PreOmics develops innovative tools and technologies aimed at enhancing protein analysis for researchers worldwide. The company's flagship product, the iST Kit, facilitates rapid and reproducible preparation of peptide mixtures from various starting materials, streamlining the sample preparation process within just one hour. PreOmics also offers high-throughput processing accessories and a robust platform that leverages liquid chromatography coupled with mass spectrometry to enable comprehensive protein identification, quantification, and analysis of post-translational modifications. Through its advanced solutions, PreOmics supports the scientific community in accelerating discovery and understanding of protein interactions and functions.

Prolab Instruments

Acquisition in 2022
Prolab Instruments is a Swiss technology company that specializes in low-flow, high-precision liquid chromatography technology and systems. The company develops analytical instruments tailored for the pharmaceutical industry, focusing on enhancing the efficiency and accuracy of liquid chromatography processes. Its proprietary mobile injection unit technology is designed to integrate the injector valve and loop, allowing the unit to move to each sample vial, thereby minimizing carry-over and improving the reliability of analytical results. Through its innovative solutions, Prolab Instruments aims to meet the evolving needs of its clients in the pharmaceutical sector.

Molecubes

Acquisition in 2021
Molecubes is a spin-off from Ghent University, founded with the support of iMinds, specializing in the development of preclinical imaging systems. The company offers a modular benchtop platform designed for the flexible in vivo scanning of laboratory animals, enabling researchers to conduct high-performance SPECT/CT and PET/CT studies. Their innovative imaging cubes are compact enough to fit in various lab spaces, facilitating the combination of different imaging modalities. With a focus on user-friendly design, Molecubes provides intuitive wireless acquisition and reconstruction software, making the systems accessible to a wide range of users. The company's solutions prioritize ease of use and effective servicing, reflecting the insights of engineers who are also end-users, thereby enhancing the daily imaging practices of researchers in the field.

Acuity Spatial Genomics

Acquisition in 2021
Acuity Spatial Genomics specializes in spatial 3D genomic and multi-omic analysis, providing innovative tools for discovery in biological research. The company’s platform enables simultaneous, genome-wide visualization of the 3D genome in individual cells, utilizing its proprietary OligoFISSEQ and OligoFISSEQ HD technologies. This approach allows researchers to examine the organization of the genome and the 3D chromatin architecture directly in situ. By offering a time-efficient and cost-effective solution, Acuity Spatial Genomics facilitates deeper insights into transcription regulatory programs that influence cell types, states, functions, and disease mechanisms.

Adeptrix

Series A in 2021
Adeptrix is a developer and manufacturer of advanced analytical reagents and assays based on its proprietary Bead Assisted Mass Spectrometry (BAMS) platform technology. This innovative system enables rapid, precise, and sensitive detection of target analytes through immunoassays measured by MALDI mass spectrometry. BAMS is characterized by its multiplexing capability, allowing multiple target analytes to be measured in a single assay, and its high-throughput capacity, which facilitates the analysis of hundreds to thousands of assays daily. Adeptrix's technology is designed for various bio-analytical applications, particularly in drug development, basic research, and clinical diagnostics. By utilizing biomarkers to monitor key signaling proteins, the company provides a novel tool for proteomics that enhances the drug discovery process by enabling the identification of suitable peptides from complex biological mixtures.

Ionpath

Series B in 2020
IonPath Inc., established in 2014 and headquartered in Menlo Park, California, specializes in multiplexed ion beam imaging services for pathology. The company's core technology surpasses light microscopy, enabling it to analyze fresh, frozen, or FFPE tissues with high precision. This allows healthcare providers to diagnose cancer more accurately, ultimately improving human health through better insights into the tissue microenvironment at a single-cell level.

PrognomIQ

Venture Round in 2020
PrognomiQ is a technology company specializing in transforming the early detection and treatment of complex diseases like cancer. It generates comprehensive proteomic, genomic, and metabolomic data to provide insights into these conditions, aiming to enhance patient outcomes. The company's innovative approach involves developing advanced test products that improve understanding and management of health issues by integrating diverse health data types.

Canopy Biosciences

Acquisition in 2020
Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

PMOD Technologies

Acquisition in 2019
PMOD Technologies LLC, founded in 2003 as a spin-off from the University Hospital PET Center in Zurich, Switzerland, specializes in developing software quantification tools for biomedical imaging in human and animal research. Originating from early developments in PET imaging, the PMOD software has evolved into a comprehensive suite of user-friendly and powerful tools that address key tasks such as kinetic modeling, parametric mapping, image registration, 3D rendering, and pattern analysis. Serving over 550 sites and more than 1,000 active users globally, PMOD Technologies aims to meet the diverse needs of researchers in the field of molecular imaging. The company continuously enhances its software functionality, extending its capabilities to include adjacent disciplines like functional MRI and CT. Collaborations with leading institutions further ensure that PMOD's offerings remain at the forefront of biomedical imaging technology, providing exceptional support and services to researchers engaged in experimental work.

Arxspan

Acquisition in 2019
Arxspan offers a comprehensive suite of cloud-based applications designed to facilitate project-based research and development collaboration across various industries, including biotechnology, pharmaceuticals, academia, cosmetics, electronics, materials, and chemicals. The company's solutions include electronic lab notebooks, registration tools for chemistry and biology, inventory management, and workflow coordination, enabling clients to centralize data and make informed scientific decisions. With a platform-independent user interface that seamlessly integrates with existing enterprise knowledge management tools, Arxspan allows users to manage multiple teams both locally and globally through a web browser. Its client base comprises large multinational companies and organizations that seek enhanced coordination of research efforts and data management across collaborative projects.

Alicona Imaging

Acquisition in 2018
Alicona Imaging is a manufacturer based in Graz, Austria, specializing in optical 3D surface measurement technology. The company focuses on providing advanced metrology systems that measure form and roughness, even in complex and miniaturized geometries. This technology is essential for quality assurance in laboratories and production environments. Alicona Imaging serves various industries, including machine tools, medical technology, forensic science, and microelectronics, enabling clients to enhance product development and optimize processes.

JPK In­stru­ments

Acquisition in 2018
JPK Instruments AG specializes in the manufacture of nano-analytical instruments tailored for life sciences and soft matter applications. The company is known for its atomic force microscopy (AFM) products, which are utilized in diverse fields such as BioAFM, polymer research, surface science, and nanooptics. Additionally, it offers automated force spectroscopy systems that facilitate real-time analysis of molecular interactions at the nanoscale. JPK Instruments also develops force-sensing optical tweezers and 3D particle tracking solutions, which are crucial for quantifying molecular, cellular, and micro-rheological processes. Their products are designed to study various phenomena, including molecular motor mechanics and cell membrane dynamics. Furthermore, the company provides tools to measure single cell-cell and cell-surface interactions under physiological conditions. Founded in 1999 and headquartered in Berlin, Germany, JPK Instruments operates through distributors both domestically and internationally and functions as a subsidiary of Bruker Corporation.

Luxendo

Acquisition in 2017
Luxendo is a company that specializes in the development and manufacture of advanced Single Plane Illumination Microscopes (SPIM), a technology initially developed at the European Molecular Biology Laboratory (EMBL). By utilizing a light-sheet fluorescence microscopy technique, Luxendo's instruments facilitate rapid three-dimensional imaging of living organisms, including spheroids and whole specimens, without the need for sample rotation. This innovative approach allows for gentle handling of delicate samples, such as cell cultures and embryonic specimens, enabling scientists to observe living organisms over extended periods while minimizing photodamage. The company's commitment to revolutionizing bio-imaging positions it as a leader in the field of microscopy, providing researchers with powerful tools for biological exploration.

Hysitron

Acquisition in 2017
Hysitron Incorporated is a subsidiary of Bruker Corporation that specializes in the development, manufacturing, and commercialization of nanomechanical test instruments. Since its founding in 1992, Hysitron has been at the forefront of nanotechnology, offering advanced solutions for measuring the mechanical properties of materials at the nanoscale. The company's innovative nanoindentation products are widely utilized by leading academic and industrial researchers, as well as engineers across materials science, life sciences, and semiconductor sectors. By providing cutting-edge technology and in-situ imaging capabilities, Hysitron supports the ongoing advancement of material development and research.

InVivo Biotech Services

Acquisition in 2017
InVivo Biotech Services is a prominent contract manufacturing organization based in Hennigsdorf, Germany, specializing in the development and production of monoclonal antibodies and recombinant proteins. With over 18 years of experience in mammalian cell culture and protein production, InVivo offers a comprehensive range of biotech services, including cloning, screening, recombinant expression of antigens, generation of hybridoma cell lines, and characterization of antibodies. The company is ISO 9001 certified and serves a diverse clientele, ranging from small university spin-offs to major research institutes and biopharmaceutical companies, providing reliable and cost-effective outsourcing solutions tailored to various needs in the biotechnology sector.

SCiLS

Acquisition in 2017
SCiLS GmbH, based in Bremen, Germany, specializes in developing software solutions tailored for the analysis and exploration of mass spectrometry data. The company provides innovative tools that include statistical analysis software, advanced visualization viewers, and secure cloud-based services, which facilitate collaborative interpretation of complex mass spectrometry imaging data sets. As a subsidiary of Bruker Corporation, SCiLS focuses on enhancing the capabilities of researchers and scientists in the field of mass spectrometry through its sophisticated software offerings.

OncoVision

Acquisition in 2016
OncoVision, a Spanish technology start-up founded in 2003, specializes in the development of advanced medical imaging devices aimed at enhancing cancer diagnosis and treatment. The company focuses on molecular vision technologies, which provide innovative diagnostic tests and therapeutic approaches with significant clinical and economic benefits. By integrating multimodal imaging solutions into surgical and interventional practices, OncoVision empowers healthcare professionals to improve patient outcomes and quality of life. The firm is backed by strong intellectual property and has garnered recognition from prestigious Spanish and European institutions for its contributions to health sciences, particularly in neurology, oncology, and cardiology. With a dynamic team composed of scientists, technicians, and technologists, OncoVision has established itself as a leader in the health technology sector, holding numerous accolades and a track record of impactful research and development in medical imaging.

Yingsheng Technology

Acquisition in 2016
Yingsheng Technology Pty Ltd. in Brisbane, Australia, that relate to the 3rd generation Advanced Mineral Identification and Characterization System (AMICS) software package, and respective IP for advanced minerals identification and characterization. AMICS is a highly innovative software platform for automated identification and quantification of mineral and synthetic phases. It can be used in conjunction with either scanning electron microscopes (SEM) and SEM-related energy dispersive X-ray spectrometers (EDS), or now also with novel micro X-ray fluorescence (µXRF) analyzers.

Jordan Valley Semiconductors

Acquisition in 2015
Jordan Valley Semiconductors, Inc. specializes in providing X-ray metrology solutions tailored for the global semiconductor industry. Founded in 1982 and headquartered in Austin, Texas, the company develops a range of metrology and defect inspection tools that utilize advanced X-ray technologies, including X-ray reflectometry, X-ray fluorescence, and high-resolution X-ray diffractometry. Its products serve various applications such as front-end and back-end semiconductor processes, wafer-level packaging, and compound semiconductors, ensuring precise characterization of thin films and multi-layer stacks. The company's offerings include systems for measuring ultra-thin film thickness, detecting crystalline defects, and supporting the production of various semiconductor materials. With manufacturing and research facilities in Migdal Ha'Emek, Israel, and Durham, United Kingdom, as well as a demo lab in Austin, Jordan Valley Semiconductors also maintains sales and customer support operations across Asia, Europe, the United States, and other regions.

Prairie Technologies

Acquisition in 2013
Prairie Technologies specializes in advanced laser microscopy, focusing on two-photon and swept field confocal microscopy. The company is recognized for its pioneering contributions, notably being the first to develop a commercial two-photon system that facilitates simultaneous imaging and uncaging using two lasers. Founded in 1995, Prairie Technologies continually enhances its product offerings by collaborating with prominent scientists and researchers globally. The company provides a diverse range of products, including two-photon microscopes, confocal microscopes, and upgrades for third-party systems, as well as UV photolysis systems and laser launches equipped with AOTF control and optical fiber outputs. Prairie Technologies is committed to supporting its entire product line, ensuring that quality and outstanding service remain at the forefront of its operations.

SkyScan

Acquisition in 2012
SkyScan designs, manufactures, markets and services instruments for 3D X-ray micro-CT imaging for customers in materials and life science. SkyScan is located close to Antwerp, Belgium.

Michrom Bioresources

Acquisition in 2011
Michrom Bioresources specializes in the manufacturing and supply of microfluidic products tailored for life science applications. The company offers a range of equipment, including liquid chromatography (LC) instrumentation, mass spectrometry (MS) accessories, and consumables. Among its innovative products are the nanoflow ultra-high performance liquid chromatography (UHPLC) system and proprietary CaptiveSpray Ionization (CSI) sources, designed for integration with mass spectrometry in proteomics and various other life science fields. Michrom Bioresources serves a diverse clientele, including biotech, pharmaceutical, clinical, academic, and governmental research laboratories, providing essential tools for advanced research and development.

Accel Instruments GmbH

Acquisition in 2009
ACCEL Instruments GmbH, a privately held supplier of scientific research instruments and proton therapy systems for cancer treatment.

S.I.S. Surface Imaging Systems

Acquisition in 2008
S.I.S. develops, manufactures and distributes advanced atomic force/scanning probe microscopy systems (AFM/SPM) for numerous applications in materials research, including semiconductors, data storage, electronic materials, solar cells, polymers and catalysts. AFM/SPM is a well-established method for ultra-high spatial resolution surface imaging and the characterization of surfaces down to atomic dimensions.

JUWE Laborgeraete

Acquisition in 2008
JUWE Laborgeraete GmbH manufactures analysers and surface area measuring apparatus. The company provides analysers for oxygen, nitrogen, and hydrogen in solids, as well as for carbon and sulphur in ferrous, non-ferrous, and organic materials. It also offers environmental measuring instruments, such as work hygiene, emission measurements, ambient air measurements, and specific surface area determination, as well as systems for water, soil, sludge, and refuse analysis. JUWE Laborgeraete GmbH was founded in 1997 and is based in Viersen, Germany.

Quantron

Acquisition in 2006
Quantron GmbH designs and manufactures optical emission spectrometers for the analysis of metals worldwide. It serves the steel, cast iron, aluminium, solder, and copper industries.

KeyMaster Technologies

Acquisition in 2006
KeyMaster Technologies specializes in the development and manufacturing of portable hand-held X-ray fluorescence (XRF) systems. These advanced systems are designed for a variety of applications, including anti-counterfeiting measures, brand protection, and security-related solutions. KeyMaster's tracer handheld XRF analyzers provide spectral analysis through user-friendly Windows CE-based software, enabling precise material identification. Their technology is utilized across multiple industries, such as automotive and aerospace, for tasks like metals and alloy analysis, as well as positive material identification. Additionally, the company's solutions include elemental tagging for secure documents, ensuring the retention of brand identity and value.

Roentec AG

Acquisition in 2005
Rontec is a manufacturer German of measuring intruments by X-rays. Their specialty are the detectors semiconductors for energy-dispersive x-ray spectroscopy , and in particular the undoped silicon detectors ( silicon sensor diffusion , drift silicon detector ). The doped silicon detectors must be cooled on the one hand to reduce background noise , on the other hand to prevent the migration of dopant; the advantage of undoped detectors is that they need to be much less cooled, especially do not require any liquid nitrogen . They also produce devices implementing these detectors, mostly devices XRF and XRD portable

Princeton Gamma-Tech Instruments

Acquisition in 2005
Princeton Gamma Tech Instruments, Inc. develops and manufactures detection equipment used in the homeland security and industrial markets. The company manufactures gamma-ray and x-ray detectors for the nuclear spectroscopy and research sector. The company is based in Princeton, New Jersey.

Socabim

Acquisition in 2005
Socabim is designs, develops, and markets solutions for X-ray materials research and analytical applications.

VACUUMSCHMELZE

Acquisition in 2003
VACUUMSCHMELZE is a manufacturer specializing in advanced magnetic materials and components. The company develops, produces, and distributes highly specialized magnetic alloys and materials characterized by exceptional magnetic and physical properties. Its diverse product offerings cater to various sectors, including automotive systems, electrical installation technology, energy conversion and distribution, industrial automation and robotics, retail, and renewable energy. With a strong emphasis on innovation and technical expertise, VACUUMSCHMELZE strives to maintain a sustainable competitive advantage in the market.

MAC Science

Acquisition in 2002
MAC Science was founded in 1987, and has become a significant competitor participant in the Japanese in X-ray and thermal analysis instrumentation market. MAC Science focuses on X-ray analysis instrumentation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.